Results 21 to 30 of about 326,497 (313)

The Hyperpolarization-Activated Cyclic-Nucleotide-Gated Channel Blocker Ivabradine Does Not Prevent Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia

open access: yesFrontiers in Pharmacology, 2020
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited, stressed-provoked ventricular arrhythmia. CPVT is treated by β-adrenergic receptor blockers, Na+ channel inhibitors, sympathetic denervation, or by implanting a defibrillator ...
Hanna Bueno-Levy   +8 more
doaj   +1 more source

Role of Heat Shock Proteins in Atrial Fibrillation: From Molecular Mechanisms to Diagnostic and Therapeutic Opportunities

open access: yesCells, 2022
Heat shock proteins (HSPs) are endogenous protective proteins and biomarkers of cell stress response, of which examples are HSP70, HSP60, HSP90, and small HSPs (HSPB).
Daiqi Liu   +5 more
doaj   +1 more source

Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab

open access: yesFrontiers in Physiology, 2021
BackgroundCombined treatment with anthracyclines (e.g., doxorubicin; Dox) and trastuzumab (Trz), a humanized anti-human epidermal growth factor receptor 2 (HER2; ErbB2) antibody, in patients with HER2-positive cancer is limited by cardiotoxicity, as ...
Claudia Altomare   +19 more
doaj   +1 more source

Molecular Insights in Atrial Fibrillation Pathogenesis and Therapeutics: A Narrative Review

open access: yesDiagnostics, 2021
The prevalence of atrial fibrillation (AF) is bound to increase globally in the following years, affecting the quality of life of millions of people, increasing mortality and morbidity, and beleaguering health care systems.
Konstantinos A. Papathanasiou   +13 more
doaj   +1 more source

Role of Pulmonary Vein in Atrial Fibrillation

open access: yesMajalah Kardiologi Indonesia, 2013
Background. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in1–2% of the general population and likely to increase in next 50 years.
Dian Andina Munawar, Yoga Yuniadi
doaj   +1 more source

Symptomatic Myocardial Bridging Treated by Coronary Stenting

open access: yesMajalah Kardiologi Indonesia, 2014
Background : Myocardial bridging is a congenital coronary anomaly with mostly benign course throughout life. However, several pathological clinical manifestations may accompany myocardial bridging, such as arrhythmia, angina, depressed left ventricular ...
Johan Winata   +3 more
doaj   +1 more source

Research Progress on Effects of Ginsenoside Rg2 and Rh1 on Nervous System and Related Mechanisms

open access: yesMolecules, 2023
Neurological-related disorders are diseases that affect the body’s neurons or peripheral nerve tissue, such as Parkinson’s disease (PD) and Alzheimer’s disease (AD).
Silu Liu   +5 more
doaj   +1 more source

Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review

open access: yesJournal of Cardiothoracic Surgery, 2010
Atrial Fibrillation (AF) is the most common arrhythmia occurring after cardiac surgery. Its incidence varies depending on type of surgery. Postoperative AF may cause hemodynamic deterioration, predispose to stroke and increase mortality.
Baikoussis Nikolaos G   +4 more
doaj   +1 more source

A Case for Pharmacogenomics in Management of Cardiac Arrhythmias

open access: yesIndian Pacing and Electrophysiology Journal, 2012
Disorders of the cardiac rhythm are quite prevalent in clinical practice. Though the variability in drug response between individuals has been extensively studied, this information has not been widely used in clinical practice.
Gaurav Kandoi   +3 more
doaj   +1 more source

The anabolic steroid stanozolol is a potent inhibitor of human MutT homolog 1

open access: yesFEBS Letters, EarlyView.
MutT homolog 1 (MTH1) is a member of the NUDIX superfamily of enzymes and is an anticancer drug target. We show that stanozolol (Stz), an anabolic steroid, is an unexpected nanomolar inhibitor of MTH1. The X‐ray crystal structure of the human MTH1–Stz complex reveals a unique binding scaffold that could be utilized for future inhibitor development ...
Emma Scaletti Hutchinson   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy